Insights on Clinical Trials

  1. A New 30-Color Spectral Flow Cytometry Panel For T Cell Therapy Phenotypic Characterization 2/12/2025

    Explore how Labcorp's 30-color immunophenotyping panel, powered by Cytek Aurora™ Spectral Flow Cytometry, can enhance your T cell therapy studies across in vitro, preclinical, and clinical stages.

  2. Accelerating CAR T-Cell Therapy Clinical Trial Timelines With Biomarker-Driven Strategies 2/12/2025

    Explore how leveraging a comprehensive biomarker strategy can accelerate clinical trial timelines and improve outcomes for CAR T-cell therapies in oncology and beyond.

  3. Treating AMD With A Novel Stem Cell Therapy 2/12/2025

    Discover how preclinical studies are advancing stem cell therapies for Age-Related Macular Degeneration (AMD) and accelerating the path to clinical trials.

  4. Supporting A Rapidly Growing Biotech With A Unique Ocular Gene Therapy 2/12/2025

    An emerging biotech developing a viral vector-based gene therapy needed a flexible and experienced partner to navigate the complex transition from preclinical studies to first-in-human trials.

  5. Searching For The Oasis In A "Cardiology Desert" 2/12/2025

    Dr. Charles Bridges, a leading cardiac surgeon, identifies the contributing factors to cardiac care obstacles and the adverse effects of “Cardiology Deserts”.

  6. Connecting The Right Patients To The Right Trial 2/6/2025

    Direct outreach to potential participants and communication with their healthcare providers is key to boosting trial awareness and participation, thereby achieving recruitment targets.

  7. 8 Critical Questions To Ask Your IRB 2/5/2025

    This article outlines eight essential questions to ask a potential IRB partner to assess their ability to help you navigate complex regulatory requirements while avoiding delays.

  8. 6 Ways Lab Data Can Improve Clinical Trials 2/3/2025

    Explore six key ways laboratory data strengthens the clinical trial process, focusing on how RWD enhances patient recruitment, accelerates screening workflows, and improves overall study outcomes.

  9. 6 Key Ways Real-World Data Is Accelerating Breast Cancer Therapies 2/3/2025

    Real-world data (RWD) is increasingly vital for advancing breast cancer research, and leveraging TA datasets allows researchers and clinicians to address pressing challenges.

  10. 8 Key Applications Of Real-World Data In Multiple Myeloma Therapy Development 2/3/2025

    Explore how therapeutic area (TA) datasets can be leveraged to address the challenges multiple myeloma (MM) presents in the field of hematologic malignancies.